These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36400610)

  • 1. Nutritional recommendations in the prevention and treatment of atherogenic dyslipidemia.
    Pascual V; Díaz JL; Millán Nuñez-Cortés J; Pérez-Martínez P
    Clin Investig Arterioscler; 2023; 35(3):155-163. PubMed ID: 36400610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.
    Ascaso JF; Millán J; Hernández-Mijares A; Blasco M; Brea Á; Díaz Á; Mantilla T; Pedro-Botet J; Pintó X;
    Clin Investig Arterioscler; 2017; 29(2):86-91. PubMed ID: 28185675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of expert consensus to improve atherogenic dyslipidemia management.
    Millán Núñez-Cortés J; Pedro-Botet J; Brea-Hernando Á; Díaz-Rodríguez Á; González-Santos P; Hernández-Mijares A; Mantilla-Morató T; Pintó-Sala X; Simó R
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):36-44. PubMed ID: 24774262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical recommendations for the management of cardiovascular risk associated with atherogenic dyslipidemia, with special attention to residual risk. Spanish adaptation of a European Consensus of Experts.
    Grupo de trabajo de Dislipemia Aterogénica de la Sociedad Española de Arteriosclerosis y Grupo Europeo de Expertos
    Clin Investig Arterioscler; 2017; 29(4):168-177. PubMed ID: 28433209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saturated fat, carbohydrate, and cardiovascular disease.
    Siri-Tarino PW; Sun Q; Hu FB; Krauss RM
    Am J Clin Nutr; 2010 Mar; 91(3):502-9. PubMed ID: 20089734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CONSENSUS ON FATS AND OILS IN THE DIET OF S ISH ADULTS; POSITION PAPER OF THE SPANISH FEDERATION OF FOOD, NUTRITION AND DIETETICS SOCIETIES].
    Ros E; López-Miranda J; Picó C; Rubio MÁ; Babio N; Sala-Vila A; Pérez-Jiménez F; Escrich E; Bulló M; Solanas M; Gil Hernández A; Salas-Salvadó J
    Nutr Hosp; 2015 Aug; 32(2):435-77. PubMed ID: 26268073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy studies].
    Pedro-Botet J; Flores-Le Roux JA
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():17-9. PubMed ID: 25043542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Atherogenic Dyslipidemia in Spanish Hypertensive Patients and Its Relationship With Blood Pressure Control and Silent Organ Damage.
    de la Sierra A; Gorostidi M; Aranda P; Corbella E; Pintó X
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):592-8. PubMed ID: 25487323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic targets in the treatment of dyslipidemia: HDL and non-HDL cholesterol].
    Brea Hernando ÁJ
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():3-6. PubMed ID: 25043539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of diet in cardiovascular prevention].
    Jacotot B
    Ann Med Interne (Paris); 2001 Apr; 152(3):194-7. PubMed ID: 11431580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SmartLab 2.0 in cardiovascular prevention of atherogenic dyslipidemia.
    Galván Toribio R; Arrobas Velilla T; Morales Porillo C; Rico MÁ; Martínez Quesada M; León Justel A
    Clin Investig Arterioscler; 2023; 35(3):123-128. PubMed ID: 36336553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects.
    Hernández-Mijares A; Ascaso JF; Blasco M; Brea Á; Díaz Á; Mantilla T; Pedro-Botet J; Pintó X; Millán J;
    Clin Investig Arterioscler; 2019; 31(2):75-88. PubMed ID: 30262442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet, lipids, and cardiovascular disease.
    Siri-Tarino PW; Krauss RM
    Curr Opin Lipidol; 2016 Aug; 27(4):323-8. PubMed ID: 27389628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor.
    Alibasic E; Ramic E; Bajraktarevic A; Ljuca F; Batic-Mujanovic O; Zildzic M
    Med Arch; 2015 Oct; 69(5):339-41. PubMed ID: 26622090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with dyslipidemia on a self-reported diet have a healthier dietary intake than the general population. The CoLaus study.
    Marques-Vidal P; Vollenweider P; Grange M; Guessous I; Waeber G
    Clin Nutr ESPEN; 2016 Feb; 11():e33-e39. PubMed ID: 28531424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of atherogenic dyslipidemia in the primary care setting in Spain.
    Díaz Rodríguez Á; Blasco Valle M; Mantilla Morató T; Capón Alvarez J; Rodríguez de Miguel M; Rodríguez-Fortúnez P; Prada-Marcos C; Orera-Peña ML
    Clin Investig Arterioscler; 2019; 31(5):203-209. PubMed ID: 31320121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention.
    Musunuru K
    Lipids; 2010 Oct; 45(10):907-14. PubMed ID: 20524075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of the overall lipid profile.
    Blasco M; Ascaso JF;
    Clin Investig Arterioscler; 2019 Dec; 31 Suppl 2():34-41. PubMed ID: 31785850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evidence for dietary prevention and treatment of cardiovascular disease.
    Van Horn L; McCoin M; Kris-Etherton PM; Burke F; Carson JA; Champagne CM; Karmally W; Sikand G
    J Am Diet Assoc; 2008 Feb; 108(2):287-331. PubMed ID: 18237578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.